GLP-1s are reshaping healthcare: Wells Fargo
FBN · Aired Aug 20 · 5m 48sWatch Now
Already a subscriber?
Robin Wenzel, head of Wells Fargo Industry Insights, explains how GLP-1 semaglutides are reshaping the healthcare business.
Robin Wenzel, head of Wells Fargo Industry Insights, explains how GLP-1 semaglutides are reshaping the healthcare business.